All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 6 read as filed from the record and 3 are SI estimates, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
1 warning event since 2017; the latest 2019-05-01.
From the record
SciSparc Ltd.'s filings since 2017 show 1 warning event: a late-report notice (Form NT 10-K or NT 10-Q, the latest 2019-05-01) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
-1.5% a year over 3 filed years; profitable in 0 of 3.
From the record
SciSparc Ltd.'s 3 filed years say what it did: revenue went from $1 million in fiscal 2022 to $1 million in fiscal 2024, down 1.5% a year; it rose in 1 of 2 years; the deepest fall was 55% from fiscal 2023 to fiscal 2024; net income was positive in 0 of 3 of those years (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
SI estimate 1.0/10, confidence 35 of 100 (one part).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: SciSparc Ltd.'s shareholder treatment is put at 1.0 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 10% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.
What are they doing right now?
Is it financially healthy right now?
ROE -84%: lost 84¢ per shareholder dollar. Leverage 14%: owes 14¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2024-12-31, SciSparc Ltd. lost about 84 cents for every dollar of shareholders' money, and gross profitability: its products earned about 5 cents per dollar of everything the company owns. Leverage: it owed about 14 cents per dollar of assets, and net share issuance: its share count grew 1328.8% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 32% of 315 in its family; net margin -572.1%.
From the record
SciSparc Ltd.'s standing among 315 graded names in its industry family: revenue of $1 million in fiscal 2024 ranks in the bottom 26% by size; a net margin of -572.1% ranks in the bottom 35%; revenue growth of -1.5% a year over the last 2 filed years ranks in the bottom 35% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
SI estimate 5.0/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: SciSparc Ltd.'s leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 371 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
What are they set up to do next?
How much room does it have to grow?
bottom 36% of 273 in its family for room to expand.
From the record
SciSparc Ltd.'s room to grow, from the newest filed statements (fiscal 2024): cash of $2 million against no long-term debt tagged leaves 14.9% of its assets as net cash, bottom 33% of its family; cash from operations less capital spending is -390.8% of revenue (bottom 37%); a gross margin of 38.7% (bottom 23%); research spending of 130.7% of revenue (top 46%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
bottom 41% of 306 in its family for growth drivers.
From the record
SciSparc Ltd.'s growth drivers, from the filed years to fiscal 2024: revenue grew -1.5% a year over the last three filed years against -1.5% over all 3, speeding up (top 40% of its family); the newest year grew -54.6% (bottom 15%); research spending grew -5% a year (bottom 40%); capital spending grew -17.2% a year (bottom 48%) (its annual reports). SciSparc Ltd. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
SI estimate 5.3/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: SciSparc Ltd.'s expectations vs reality is put at 5.3 of 10 with a confidence of 20 of 100, because the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 234 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made